Read more: #ReimagineMedicine #NovartisUS To view or add a comment, sign in The FDA approval of a new oral, targeted therapy for chronic spontaneous urticaria (CSU) changes the treatment landscape for millions of people living with this often-overlooked disease
Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to consulting firm Mercer
Our latest article reviews the study and how DRG offers patients another option
Al hilo de esta idea, Sun duda de que la familia Ozempic sea la cura perfecta: Ms que buenos frmacos, urgen medidas de salud pblica para acceder a una alimentacin saludable.
Haenen N, Kamperman AM, Prodan A, Nolen WA, Boks MP, Wesseloo R
Regulation of auxin, abscisic acid and salicylic acid levels by ascorbate application under heat stress in sensitive and tolerant maize leaves